Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 4/20 | 0.61 |
| ▸ | MMP2 | P08253 | 3/20 | 0.61 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.43 |
| ▸ | NSD2 | O96028 | 3/20 | 0.41 |
| ▸ | F2 | P00734 | 2/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.41 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.40 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1168298 | 0.88 | MMP2 (0.46) | MMP9MMP2MMP8CA2 | |
| SCHEMBL5706285 | 0.85 | MMP9 (0.57) | MMP9MMP2NSD2MMP8MMP13 | |
| SCHEMBL5149287 | 0.85 | MMP9 (0.44) | MMP9MMP2NSD2MMP8MMP13 | |
| SCHEMBL3863364 | 0.85 | MMP9 (0.57) | MMP9MMP2NSD2MMP8MMP13 | |
| SCHEMBL4137790 | 0.84 | MMP9 (0.60) | MMP9MMP2NSD2MMP8MMP13 | |
| SCHEMBL3465132 | 0.84 | MMP9 (0.60) | MMP9MMP2NSD2MMP8MMP13 | |
| SCHEMBL6266412 | 0.84 | PKLR (0.50) | MMP9MMP2NSD2 | |
| SCHEMBL28235262 | 0.83 | ITGB3 (0.43) | MMP9MMP2NSD2F2MMP8 | |
| SCHEMBL8842858 | 0.83 | NSD2 (0.45) | MMP9NSD2MMP8MMP13ADAMTS4 | |
| SCHEMBL9670221 | 0.83 | NSD2 (0.45) | NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 592 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190294069-A1 | SECURITY LIQUID ELECTROSTATIC INK COMPOSITION | HEWLETT-PACKARD INDIGO B.V. (NL) | 2019-09-26 | — | — | US | claimed |
| US-20170266285-A1 | PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED HEMOGLOBIN-BASED THERAPEUTIC AGENT FOR CANCER TARGETING TREATMENT AND DIAGNOSTIC IMAGING | VISION GLOBAL HOLDINGS LTD. (HK) | 2017-09-21 | — | — | US | claimed |
| US-9073973-B2 | Dye conjugates of template-fixed peptidomimetics | POLYPHOR LTD. (CH) | 2015-07-07 | — | — | US | claimed |
| US-8852596-B1 | Detection of Giardia lamblia trophozoites and cysts and protection against G. lamblia infection | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2014-10-07 | — | — | US | claimed |
| EP-1594962-B1 | COVALENT TETHERING OF FUNCTIONAL GROUPS TO PROTEINS | PROMEGA CORP (US) | 2014-08-27 | — | — | EP | claimed |
| EP-2369006-B1 | Covalent tethering of functional groups to proteins | PROMEGA CORP (US) | 2014-03-12 | — | — | EP | claimed |
| EP-1879911-B1 | DYE CONJUGATES OF TEMPLATE-FIXED PEPTIDOMIMETICS | POLYPHOR LTD (CH) | 2011-08-17 | — | — | EP | claimed |
| EP-1007570-B1 | MONOSPECIFIC ANTIBODY REACTIVE WITH FIBRINOGEN AND FIBRINOPEPTIDE B | NEW YORK BLOOD CT INC (US) | 2009-06-10 | — | — | EP | claimed |
| WO-2005124351-A2 | A SENSITIVE ANTIBODY-BASED METHOD FOR DETECTING CRYPTOSPORIDIUM PARVUM OOCYSTS IN WATER | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2005-12-29 | — | — | WO | claimed |
| EP-1007570-A4 | MONOSPECIFIC ANTIBODY REACTIVE WITH FIBRINOGEN AND FIBRINOPEPTIDE B | NEW YORK BLOOD CT INC (US) | 2005-02-23 | — | — | EP | claimed |
| US-6043087-A | BINDS SPECIFICALLY WITH EPITOPE OF DEFINED AMINO ACID SEQUENCE; FOR ACCURATE DIAGNOSIS AND TREATMENT OF CLOT FORMATION, EMBOLISM, AND ATHEROSCLEROSIS | THE NEW YORK BLOOD CENTER (US) | 2000-03-28 | — | — | US | claimed |
| US-6025148-A | SPECIFICALLY REACTIVE WITH THE ALPHA E SUBUNIT; FOR DIAGNOSTIC INFORMATION RELATING TO ATHEROGENESIS AND/OR THROMBOGENESIS AND PREGNANCY STATUS OR OUTCOME | NEW YORK BLOOD CENTER, INC. (US) | 2000-02-15 | — | — | US | claimed |
| US-5985566-A | Platinum-containing compounds, methods for their preparation and applications thereof | KREATECH DIAGNOSTICS (NL) | 1999-11-16 | — | — | US | claimed |
| US-5876947-A | HYBRIDOMA CELL LINE WHICH PRODUCES MONOCLONAL ANTIBODY USED IN ACCURATE DIAGNOSIS OF THROMBOSIS AND ATHLEROSCLEROSIS | THE NEW YORK BLOOD CENTER, INC. (US) | 1999-03-02 | — | — | US | claimed |
| WO-1999005261-A1 | MONOSPECIFIC ANTIBODY REACTIVE WITH MATRIX METALLOPROTEINASE CLEAVAGE PRODUCTS OF FIBRIN(OGEN) | THE NEW YORK BLOOD CENTER, INC. (US) | 1999-02-04 | — | — | WO | claimed |
| WO-1999005176-A1 | MONOSPECIFIC ANTIBODY REACTIVE WITH FIBRINOGEN AND FIBRINOPEPTIDE B | THE NEW YORK BLOOD CENTER, INC. (US) | 1999-02-04 | — | — | WO | claimed |
| EP-0871884-A1 | MONOSPECIFIC ANTIBODIES AGAINST A SUBUNIT OF FIBRINOGEN | New York Blood Center, Inc. (US) | 1998-10-21 | — | — | EP | claimed |
| US-5817768-A | Monospecific antibodies against a subunit of fibrinogen | THE NEW YORK BLOOD CENTER, INC. (US) | 1998-10-06 | — | — | US | claimed |
| US-5714327-A | PLATINUM CONTAINING DETECTABLE PROBE COMPOUND HAVING MARKER MOIETY, STABILIZING SUBSTITUENTS, BIOMOLECULE | KREATECH DIAGNOSTICS (NL) | 1998-02-03 | — | — | US | claimed |
| WO-1996041170-A1 | MONOSPECIFIC ANTIBODIES AGAINST A SUBUNIT OF FIBRINOGEN | THE NEW YORK BLOOD CENTER, INC. (US) | 1996-12-19 | — | — | WO | claimed |